Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Sixth Element, PhoreMost spin out immuno-oncology newco

November 17, 2017 7:20 PM UTC

Sixth Element Capital LLC invested £3 million ($4 million) in newly created NeoPhore Ltd. (Cambridge, U.K.), a spinout from cancer company PhoreMost Ltd. (Cambridge, U.K.). The newco will seek to discover and develop small molecule immuno-oncology therapies to treat undisclosed cancer indications.

NeoPhore, the first asset-centric spinout of PhoreMost, will aim to build on discoveries already made by PhoreMost and its collaborators...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article